Luthringer Remy bought NERV
December 22, 2025 · Form 4 insider transaction
Luthringer Remy bought 2,250,000 shares of Minerva Neurosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
2,250,000
Price
$0.00
Total value
N/A
InsiderLuthringer Remy
RoleOfficer, Director
SecurityEmployee Stock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateDecember 22, 2025
Filing dateDecember 23, 2025
Shares owned after2,250,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option vests 25% on December 22, 2026 and then in equal quarterly installments over 3 years thereafter.